The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Transcatheter mitral valve interventions: Eldorado or Waterloo for interventional cardiologists?

EuroIntervention 2016;12:Y56-Y57. DOI: 10.4244/EIJV12SYA13

1. Department of Cardiology, McGill University Health Center, Royal Victoria Hospital, Montreal, Quebec, Canada; 2. Department of Cardiology, University Hospital of Bern, Bern, Switzerland
Interventional cardiology is a culture endowed with innovation. Within the last 40 years, since the first percutaneous coronary intervention, the field has travelled through the panorama of bare metal stents, drug-eluting stents, bioresorbable scaffolds, percutaneous left ventricular assist devices, percutaneous shunt closure, left atrial appendage occlusion devices, transcatheter aortic valve implantation (TAVI) and, more recently, transcatheter mitral and tricuspid valve interventions. As expected, first-in-human experiences with these devices were associated with suboptimal device platforms, patient selection criteria, procedural techniques and clinical outcomes. Nonetheless, interventional cardiologists have been able to learn and adapt from their initial experiences with dramatic improvement in clinical ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
How should I treat this unusual anterolateral ST-elevation myocardial infarction with recurrent ventricular fibrillation and cardiac arrest?